ACT Capital Management’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$131K Hold
35,440
0.18% 45
2022
Q2
$117K Hold
35,440
0.16% 46
2022
Q1
$156K Hold
35,440
0.17% 56
2021
Q4
$337K Sell
35,440
-8,500
-19% -$80.8K 0.24% 55
2021
Q3
$743K Buy
43,940
+1,940
+5% +$32.8K 0.39% 46
2021
Q2
$1.17M Buy
+42,000
New +$1.17M 0.6% 36